Artículos del autor

solaci

Antiplatelet

ESC 2021 | MASTER DAPT: Dual Antiplatelet Therapy After Coronary Angioplasty in Patients at High Bleeding Risk

Courtesy of Dr. José Álvarez. In patients at high bleeding risk with drug-eluting stents, the duration of dual...
solaci -
Coronary disease

09/02 | SOLACI-MEDTRONIC Webinar : PCI Summit – High Risk Coronary Interventions (CHIP)

solaci -
ESC 2021

ESC 2021

Here are the most important scientific articles of the ESC 2021 virtual Congress. If you cannot view the...
solaci -
Chronic Ischemic cardiopathy

Post PCI Same Day Discharge: from Convenience to Need

Same day discharge following programed PCI with no complications has been a way for health centers to...
solaci -
Aorta

Fenestrated Endografts as Treatment for Type I Endoleak: What is the Price of Success?

Both fenestrated and branched endografts are effective to treat patients after failure of their initial endograft due...
solaci -
Institutional News

The Most Read Articles in Interventional Cardiology of July

01- Novel DES Technology Promises to Become the Next DES Generation The novel technology of drug-eluting stent Supreme was designed...
solaci -
Acute coronary syndromes

Dual Antiaggregation De-Escalation: A New Paradigm?

De-escalating dual antiaggregation could be the most effective strategy after acute coronary syndrome seeing as it prevents...
solaci -
Acute coronary syndromes

Complete Revascularization after Pharmacoinvasive Strategy

Patients initially receiving pharmacoinvasive strategy for ST elevation myocardial infarction (STEMI) also presenting multivessel disease consistently benefit...
solaci -